A novel antibacterial approach of Cecropin-B peptide loaded on chitosan nanoparticles against MDR Klebsiella pneumoniae isolates

Theodor Bilharz Research Institute

Bibliographic Information

Authors: Okasha H.; Dahroug H.; Gouda A.E.; Shemis M.A.

Journal: Amino Acids

Publisher: Springer

Publication Date: 15 November 2023

Volume / Issue: Volume 55 / Issue 12

Pages: 1965–1980

ISSN: 9394451

DOI: 10.1007/s00726-023-03356-4

Scopus: View on Scopus

PubMed: 37966500

Document Type: Article

Access: All Open Access; Green Open Access; Hybrid Gold Open Access


Authors and Affiliations

Okasha H., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Dahroug H., Microbiology Department, Theodor Bilharz Research Institute, Giza, Egypt; Gouda A.E., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt; Shemis M.A., Biochemistry and Molecular Biology Department, Theodor Bilharz Research Institute, Giza, Egypt


Abstract

Egypt has witnessed the emergence of multidrug-resistant (MDR) Klebsiella pneumoniae, which has posed a serious healthcare challenge. The proper treatment choice for MDR-KP infections is not well determined which renders the problem more complicated, thus making the control of such infections a serious challenge for healthcare professionals. This study aims to encapsulate the cationic antimicrobial peptide; Cecropin-B (Cec-B), to increase its lifetime, drug targeting, and efficacy and study the antimicrobial effect of free and encapsulated recombinant rCec-B peptide on multidrug-resistant K. pneumoniae (MDR-KP) isolates. Fifty isolates were collected from different clinical departments at Theodore Bilharz Research Institute. Minimal inhibitory concentrations (MICs) of rCec-B against MDR-KP isolates were determined by the broth microdilution test. In addition, encapsulation of rCec-B peptide into chitosan nanoparticles and studying its bactericidal effect against MDR-KP isolates were also performed. The relative expression of efflux pump and porin coding genes (ArcrB, TolC, mtdK, and Ompk35) was detected by quantitative PCR in treated MDR-KP bacterial isolates compared to untreated isolates. Out of 60 clinical MDR isolates, 50 were MDR-KP. 60% of the isolates were XDR while 40% were MDR. rCec-B were bactericidal on 21 isolates, then these isolates were subjected to treatment using free nanocapsule in addition to the encapsulated peptide. Free capsules showed a mild cytotoxic effect on MDR-KP at the highest concentration. MIC of encapsulated rCec-B was higher than the free peptide. The expression level of genes encoding efflux and porin (ArcrB, TolC, mtdK, and Ompk35) was downregulated after treatment with encapsulated rCec-B. These findings indicate that encapsulated rCec-B is a promising candidate with potent antibacterial activities against drug-resistant K. pneumoniae. © 2023, The Author(s).


Keywords

Antibacterial; Bactericidal; Cationic antimicrobial peptide; Cecropin; Chitosan; Egypt; Klebsiella pneumoniae; Multidrug-resistant; Nanocapsule; PCR; Anti-Bacterial Agents; Cecropins; Humans; Klebsiella Infections; Microbial Sensitivity Tests; Nanoparticles; Porins; nanoparticle; antiinfective agent; porin; antibacterial activity; ArcrB gene; Article; bacterial gene; bacterium isolation; broth dilution; down regulation; drug cytotoxicity; drug efficacy; drug formulation; drug targeting; drug transport; Fourier transform infrared spectroscopy; gene expression level; gene expression regulation; hemolysis; minimum inhibitory concentration; mtdK gene; multidrug resistant Klebsiella pneumoniae; nanoencapsulation; nonhuman; Ompk35 gene; physical parameters; real time polymerase chain reaction; swelling kinetics; TolC gene; zeta potential; genetics; human; Klebsiella infection; microbial sensitivity test; microbiology


Citation Information

Scopus Citations: 16


For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.

The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.

English Website: https://www.tbri.sci.eg/en/

Arabic Website: https://www.tbri.sci.eg/ar/

Prepared and Uploaded by:

Abdalla F. Abdalla

Electronic Portal Unit

Electronic Portal Unit

Popular Posts

A cost-performance index for nano-optical biosensor evaluation: Systematic evaluation of europium–salicylate luminescent platforms for GPC3-targeted early HCC diagnosis

Interpretation of liver stiffness measurement in patients with mixed liver disease etiologies

Mytilus edulis-mediated green synthesis of selenium nanoparticles with antimicrobial and molluscicidal applications

Variable clinical presentations of pulmonary hydatid cysts: a four-case series from a single center in United Arab Emirates, non-endemic region

Holothuria arenicola Extract-Loaded Polycaprolactone Nanocapsules Attenuate Bile Duct Ligation-Induced Acute Liver Injury

Corrigendum to ‘Eco-friendly approach for the removal and simultaneous detection of cyanide toxins from drinking and wastewater sources’ [Environ. Pollut. 385 (2025) 127094]

Microbial levan potentiates hepatic retention and antitumor activity of a PEGylated benzimidazole–curcumin nanocomplex through TLR2–FXR/FGF15-associated immunometabolic remodeling in experimental liver cancer